JP2009529037A5 - - Google Patents

Download PDF

Info

Publication number
JP2009529037A5
JP2009529037A5 JP2008558220A JP2008558220A JP2009529037A5 JP 2009529037 A5 JP2009529037 A5 JP 2009529037A5 JP 2008558220 A JP2008558220 A JP 2008558220A JP 2008558220 A JP2008558220 A JP 2008558220A JP 2009529037 A5 JP2009529037 A5 JP 2009529037A5
Authority
JP
Japan
Prior art keywords
peptide
amino acids
radiation
pharmaceutical composition
wbi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008558220A
Other languages
English (en)
Japanese (ja)
Other versions
JP5307559B2 (ja
JP2009529037A (ja
Filing date
Publication date
Priority claimed from EP06076181A external-priority patent/EP1864692A1/en
Application filed filed Critical
Publication of JP2009529037A publication Critical patent/JP2009529037A/ja
Publication of JP2009529037A5 publication Critical patent/JP2009529037A5/ja
Application granted granted Critical
Publication of JP5307559B2 publication Critical patent/JP5307559B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008558220A 2006-03-07 2007-03-06 放射線障害の制御の為にペプチドを使用する方法 Expired - Fee Related JP5307559B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US77989606P 2006-03-07 2006-03-07
US60/779,896 2006-03-07
US81187806P 2006-06-07 2006-06-07
EP06076181A EP1864692A1 (en) 2006-06-07 2006-06-07 Use of peptides for the control of radiation injury
US60/811,878 2006-06-07
EP06076181.4 2006-06-07
PCT/NL2007/050092 WO2007102735A1 (en) 2006-03-07 2007-03-06 Use of peptides for the control of radiation injury

Publications (3)

Publication Number Publication Date
JP2009529037A JP2009529037A (ja) 2009-08-13
JP2009529037A5 true JP2009529037A5 (enExample) 2010-04-22
JP5307559B2 JP5307559B2 (ja) 2013-10-02

Family

ID=41036775

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008558220A Expired - Fee Related JP5307559B2 (ja) 2006-03-07 2007-03-06 放射線障害の制御の為にペプチドを使用する方法

Country Status (3)

Country Link
JP (1) JP5307559B2 (enExample)
CN (1) CN101443080B (enExample)
IL (1) IL193910A (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6378307B2 (ja) * 2013-03-11 2018-08-22 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 肺機能を改善するためならびに放射線誘発肺合併症の予防および／または処置のための物質および方法
CN108484738B (zh) * 2018-03-28 2022-03-15 中国人民解放军军事科学院军事医学研究院 辐抗肽突变蛋白及其制备与纯化方法
CN118546262B (zh) * 2024-06-20 2025-07-29 首都医科大学 Ala-Gln-Gly的四聚体及其制备和应用
CN121102437A (zh) * 2025-11-07 2025-12-12 复旦大学 一种多肽在制备治疗放射性肠损伤药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0572688T3 (da) * 1992-05-30 1997-12-01 Sikiric Predrag Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
JP2860637B2 (ja) * 1995-12-11 1999-02-24 末綱 陽子 新規なペプチドおよび活性化酸素阻害剤
JP2835504B2 (ja) * 1995-12-11 1998-12-14 末綱 陽子 新規なペプチドおよび活性化酸素阻害剤
JP3368735B2 (ja) * 1995-12-26 2003-01-20 住友金属工業株式会社 高強度・低延性非調質鋼
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
CN1108169C (zh) * 1999-06-24 2003-05-14 中国医学科学院血液学研究所 一种用于辐射损伤治疗的多肽类药物组合物
DE60110396T2 (de) * 2000-01-14 2006-01-19 Larson, Richard S., Albuquerque Peptidische inhibitoren der lfa-1/icam-1 interaktion
WO2004048971A1 (en) * 2002-11-25 2004-06-10 Sciclone Pharmaceuticals, Inc. Methods of protecting against radiation damage using alpha thymosin

Similar Documents

Publication Publication Date Title
CY1120014T1 (el) Αντισωματα συνδεσης πρωτοϊνιδιου και χρηση αυτων σε θεραπευτικες και διαγνωστικες μεθοδους για ασθενεια parkinson, ανοια με σωματα lewy και αλλες αλφα-συνουκλεϊνοπαθειες
RU2016119745A (ru) Модели рака и соответствующие способы
BRPI0512893B8 (pt) métodos de determinação da eficácia da terapia no tratamento da amiloidose e de identificação de paciente como prodrômico para doença associada com a deposição amilóide e respectivos compostos
DE60110912D1 (de) Valproinsäure und deren derivate als histondeacetylaseinhibitoren
ES2539490T3 (es) Métodos para proteger frente a apoptosis usando lipopéptidos
WO2012036433A3 (ko) miRNA를 타겟으로 한 신경퇴행성 질환 치료
JP2009529037A5 (enExample)
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
JP2018519366A5 (enExample)
EA200800663A1 (ru) Способ и средство профилактики и лечения нарушенного дыхания во время сна
BR112012003390A2 (pt) método de radioiodação de uma unidade de marcação biológica, composto, composição radiofarmacêutica, método de preparação do composto, usos de um compsto, e de um aparelho sintetizador automatizado, cassete estéril, de uso único, e, métodos para gerar uma imagem de um corpo de animal ou de humano, e para monitorar o efeiro de tratamento de um corpo de aninmal ou de humano com uma droga.
RU2015135635A (ru) Способ обработки экстракта из морских водорослей, экстракт, фармацевтическая композиция, биоматериал, способ лечения, применение экстракта и композиции
Wang et al. Effect of delta opioid receptor activation on spatial cognition and neurogenesis in cerebral ischemic rats
WO2015026494A2 (en) Methods for treating tissue fibrosis
JP2016026189A (ja) 放射線および熱の複合損傷の治療方法
JP2013523659A5 (enExample)
DE11786796T1 (de) Antigenpeptid und verwendung davon
JP6660877B2 (ja) アミロイド−β−結合性ペプチド、ならびにアルツハイマー型認知症の治療および診断のためのその使用
RU2006138495A (ru) Использование агонистов рецепторов, активируемых пролифератором пероксисомы дельта для лечения рс и других демиелинизирующих заболеваний
Wang et al. A mouse model of peripheral nerve injury induced by Japanese encephalitis virus
WO2007107323A3 (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
TW200718783A (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
Kholghi et al. Intraperitoneal injection of buprenorphine on anxiety-like behavior and alteration in expression of Gfap and Nrf2 in methamphetamine treated rats
JP2008518020A5 (enExample)
Sun et al. A pH-Triggered self-releaseing humic acids hydrogels loaded with porcine interferon α/γ achieves anti-PRV effects by oral administration